Viewing Study NCT05879367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-02 @ 7:01 PM
Study NCT ID: NCT05879367
Status: RECRUITING
Last Update Posted: 2025-06-25
First Post: 2023-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Sponsor: Orbus Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma, IDH-wildtype View
None Glioblastoma View
None Glioblastoma Multiforme View
None Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype View
None GBM View
None Astrocytoma View
None Astrocytoma, IDH-Mutant View
Keywords: